Verification of Risk Factors of Thrombohemorrhagic Compli... | NCT06169592

Status Module

Record Verification Date

Jul 2025

Overall Recruitment Status or Expanded Access Status

Recruiting

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Apr 22, 2022Actual

Primary Completion Date

Nov 14, 2026Estimated

Completion Date

Dec 16, 2026Estimated

First Submitted Date

Dec 5, 2023

First Submission Date that Met QC Criteria

Dec 5, 2023

First Posted Date

Dec 13, 2023Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Dec 29, 2025

Last Update Posted Date

Dec 30, 2025Actual

Sponsor/Collaborators Module

Responsible Party, by Official Title

Azam Babadjanov, Professor, Republican Specialized Scientific and Practical Medical Center of Surgery Named After V. VakhidovPrincipal Investigator

Lead Sponsor

Republican Specialized Scientific and Practical Medical Center of Surgery Named After V. VakhidovOTHER

Collaborators

Not provided

Oversight Module

Has Data Monitoring Committee (DMC)

Not provided

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

The aim of the study is to improve the results of related transplantation of the right liver lobe by verifying the general predictors of the development of hemostatic system disorders and optimizing a comprehensive program for thrombohemorrhagic complications preventing.

Detailed Description

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

30Estimated

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
liver transplant group			Procedure: Liver transplantation

Interventions

Name	Type	Description	Arm Group Labels	Other Names
Liver transplantation	Procedure	Related transplantation of the right lobe of the liver	liver transplant group

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Thrombosis of vascular anastomosis	Thrombosis of arterial or venous anastomosis after intervention	1 month

Secondary Outcomes

Measure	Description	Time Frame
Hemorrhagic complications	Any hemorrhagic complications after intervention	1 month

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Age over 18 years and up to 70 years;
Signed informed consent for inclusion to the study;
End stage liver cirrhosis.

Exclusion Criteria:

Pregnancy;
Extrahepatic factors influencing systemic hemostasis;
Concomitant hematological diseases affecting the hemostatic system;
Severe concomitant disorders.

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

70 Years

Standard Ages

AdultOlder Adult

Study Population

Patients with end stage liver cirrhosis who underwent living related liver transplantation.

Sampling Method

Probability Sample

Contacts/Locations Module

Central Contacts

Name	Role	Phone	Extension	Email
Azam Babadjanov, Professor	Contact	+998901751703		azambabadjanov@gmail.com

Overall Officials

Not provided

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Republican specialized scientific and practical medical center of surgery named after academician V.Vakhidov	Recruiting	Tashkent		100115	Uzbekistan

IPD Sharing Statement Module

Plan to Share IPD

Undecided

Description

Not provided

Types

Not provided

Time Frame

Not provided

Access Criteria

Not provided

URL

Not provided

Derived Section

Miscellaneous Info Module

Version Holder

Jul 10, 2026

Removed Countries

Not provided

Submission Tracking

No data available

No data is available for this block.

Condition Browse Module

MeSH Terms

Intervention Browse Module

MeSH Terms

ID	Term
D008107	Liver Diseases
D004066	Digestive System Diseases
D005355	Fibrosis
D010335	Pathologic Processes
D013568	Pathological Conditions, Signs and Symptoms

ID	Term
D016378	Tissue Transplantation
D064987	Cell- and Tissue-Based Therapy
D001691	Biological Therapy
D013812	Therapeutics
D013505	Digestive System Surgical Procedures
D013514	Surgical Procedures, Operative
D016377	Organ Transplantation
D014180	Transplantation